Washington, DC 20549


Pursuant To Section 13 or 15(d) of the Securities Exchange Act of 1934

Date of report (Date of earliest event reported): May 6, 2021 (May 6, 2021)

(Exact Name of Registrant as Specified in Charter)
Maryland 001-37401 46-5212033
(State or other jurisdiction of incorporation) (Commission File Number) (I.R.S. Employer
Identification No.)

3326 Aspen Grove Drive, Suite 150, Franklin, Tennessee 37067
(Address of principal executive offices) (Zip Code)

(615) 771-3052
(Registrant's telephone number, including area code)

Not Applicable
(Former name or former address, if changed since last report)

Check the appropriate box below if the Form 8-K filing is intended to simultaneously satisfy the filing obligation of the registrant under any of the following provisions (see General Instruction A.2. below):

Written communications pursuant to Rule 425 under the Securities Act (17 CFR 230.425)

Soliciting material pursuant to Rule 14a-12 under the Exchange Act (17 CFR 240.14a-12)

Pre-commencement communications pursuant to Rule 14d-2(b) under the Exchange Act (17 CFR 240.14d-2(b))

Pre-commencement communications pursuant to Rule 13e-4(c) under the Exchange Act (17 CFR 240.13e-4(c))

Securities registered pursuant to Section 12(b) of the Act:
Title of each ClassTrading SymbolName of each exchange on which registered
Common stock, $0.01 par value per shareCHCTNew York Stock Exchange

Indicate by check mark whether the registrant is an emerging growth company as defined in Rule 405 of the Securities Act of 1933 (17 CFR §230.405) or Rule 12b-2 of the Securities Exchange Act of 1934 (17 CFR §240.12b-2).
Emerging growth company

If an emerging growth company, indicate by check mark if the registrant has elected not to use the extended transition period for complying with any new or revised financial accounting standards provided pursuant to Section 13(a) of the Exchange Act. ¨

Item 5.07   Submission of Matters to a Vote of Security Holders

    Community Healthcare Trust Incorporated (the "Company") held its Annual Meeting of Stockholders on May 6, 2021. At the Annual Meeting, there were present in person or by proxy 22,256,674 shares of the Company's common stock, representing approximately 92.60% of the total outstanding eligible shares. Set forth below are the voting results for the proposals considered and voted upon at the Annual Meeting of Stockholders.

1.    The election of five directors to the Board of Directors of the Company, each to serve a one-year term expiring in 2022.

The following five directors were elected based on the following vote total:
NomineeVotes ForVotes WithheldBroker Non-Votes
Alan Gardner19,613,490 1,070,075 1,573,109 
Claire Gulmi20,560,563 123,002 1,573,109 
Robert Hensley18,770,842 1,912,723 1,573,109 
Lawrence Van Horn18,875,626 1,807,939 1,573,109 
Timothy Wallace20,111,011 572,554 1,573,109 

2.     The shareholders approved, on a non-binding advisory basis, the Company’s compensation of its executive officers by the following vote:
Votes ForVotes AgainstAbstentionsBroker Non-Votes
20,334,649 306,795 42,121 1,573,109 

3.    The ratification of the appointment of BDO USA, LLP as the Company's independent registered public accounting firm for 2021.

The shareholders ratified the appointment of BDO USA, LLP based on the following vote totals:
Votes ForVotes AgainstAbstentionsBroker Non-Votes
22,233,506 3,836 19,332 


    Pursuant to the requirements of the Securities Exchange Act of 1934, the registrant has duly caused this report to be signed on its behalf by the undersigned hereunto duly authorized.
/s/ David H. Dupuy
David H. Dupuy
Executive Vice President and Chief Financial Officer
Date: May 6, 2021